Abstract: We demonstrated that XMRV
RT mutants
K103R and
Q190M, which are equivalent to HIV-1 mutants that are resistant to tenofovir (
K65R) and AZT (
Q151M), are also resistant to the respective drugs, suggesting that XMRV can acquire resistance to these compounds through the decreased incorporation mechanism reported in HIV-1.
Method: Drug resistant XMRV
RT mutants
Q190M and
K103R (equivalent to HIV-1 Q151M
RT and
K65R) were generated by site-directed mutagenesis using forward and reverse primers 2 and 3.